"Targeting the Beauty Medical Market"... Amorepacific Partners with VIOL Medical

Combining EBD Technology and Skincare:
Joint Development of Home Beauty Devices Underway

Strategic Investment Drives Expansion of Integrated Solutions Linking Professional Treatments and Home Care

Amorepacific announced on March 31 that it has signed a memorandum of understanding (MOU) with VIOL Medical, a global energy-based medical device company, to explore joint business opportunities in the beauty and medical device sectors. Through this partnership, the two companies plan to develop integrated beauty solutions that encompass both professional treatments at clinics and hospitals, as well as everyday home care.

The companies will combine VIOL Medical’s energy-based device (EBD) technology with Amorepacific’s expertise in skincare, collaborating across the entire spectrum from product planning and development to service and marketing. In particular, they will review various collaboration strategies in the home beauty device market, including joint development of beauty devices, as well as the establishment of marketing and sales strategies. To strengthen this partnership, Amorepacific has also made a strategic investment in VIOL Medical.

Through this partnership, the two companies aim to develop integrated beauty solutions that span professional treatments at clinics and hospitals and daily home care. Amorepacific plans to leverage its research capabilities in skin science and brand competitiveness to expand the potential for combining high-performance skincare with devices. Meanwhile, VIOL Medical intends to utilize its accumulated technological expertise and network in medical and aesthetic devices in the global market to broaden the scope of collaboration. By doing so, both companies aim to secure mid- to long-term growth opportunities in the field that merges beauty and medical solutions.

Seunghwan Kim, CEO of Amorepacific

Seunghwan Kim, CEO of Amorepacific, stated, “Since its founding, Amorepacific has led Korea’s beauty industry based on years of research and technological advancement in skin science. Through this collaboration with VIOL Medical, we aim to introduce integrated beauty solutions that bridge professional treatment and daily home care, delivering a differentiated customer experience in the global beauty and medical markets.”

VIOL Medical CEO Lee Euncheon also commented, “Amorepacific is a company that has built global competitiveness in skin science and skincare, making it the ideal partner to create synergy with VIOL Medical’s medical device technologies. Through this agreement, we plan to jointly design new collaborative models that connect professional treatment settings with consumer touchpoints, and explore the potential of beauty and medical convergence solutions in the global market to deliver a differentiated customer experience.”

VIOL Medical, established in 2009, develops and supplies medical devices based on microneedle RF technology. In June last year, the company was acquired by VIG Partners. VIOL Medical continues to strengthen its technological competitiveness in the aesthetic medical sector, with flagship products including Sylfirm X, Scarlett, Cellynue, and Duotight.

This content was produced with the assistance of AI translation services.